Altered host response by immunosuppression and interruptions in mucocutaneous barriers due to tumors, drug toxicity, and foreign bodies (catheters) are undoubtedly responsible for the increased susceptibility of cancer patients to infection. In addition to these predisposing factors, possible antibacterial activity of antitumor drugs has been suggested as a potential for influencing patterns of infection. Selective suppression of normal bacterial flora by antitumor drugs, thus altering colonization resistance (12) , has been proposed as an explanation for Clostridium difficileassociated colitis in cancer patients (2, 3) . Selective resistance of pathogens such as Pseudomonas aeruginosa to antineoplastic agents has been cited as an explanation for the prevalence of infection caused by this species in leukemic patients (4) . Similar resistance of certain normal human microflora, such as Staphylococcus epidermidis and coryneform bacteria, could help to explain their occurrence as opportunistic pathogens in compromised hosts (13) (14) (15) . To investigate the potential for alteration of normal bacterial ecology by antineoplastic agents, we determined the MICs of 14 antineoplastic drugs against a diverse group of 101 fresh clinical isolates or stock cultures of clinical origin representing both usual flora and selected bacterial pathogens.
Stock solutions of intravenous formulations of 5-fluorouracil (5-FU), mitomycin, etoposide (VP-16), bleomycin, carmustine, cisplatin, cyclophosphamide, cytosine arabinoside, dactarbazine, doxorubicin, methotrexate, thiotepa, vinblastine, and vincristine were prepared in sterile, preservative-free distilled water. The diluent used for the VP-16 parenteral formulation was prepared as described by Nissen et al. (11) and was tested to verify that it did not contribute any antibacterial activity. Agar dilution susceptibility tests were performed with the antineoplastic drugs by the methods of the National Committee for Clinical Laboratory Standards for aerobic (10) and anaerobic (9) bacteria. Sheep blood (5%) was added to Mueller-Hinton agar for testing fastidious aerobic species. Anaerobic bacteria were tested by using Wilkins-Chalgren agar without the addition of blood.
* Corresponding author.
The antimicrobial susceptibility results with the antitumor drugs are summarized in Table 1 . To assess the relevance of these results, the MIC obtained for each antineoplastic agent was compared with the peak plasma concentration expected after its intravenous administration (1) Based on the in vitro data presented here and the recent report of Hamilton-Miller (5), the direct influence of antineoplastic drugs on human microflora appears to be minimal. Few of the drugs showed appreciable antibacterial activities at achievable plasma levels, and there was no consistent pattern of inhibition of either usual flora or opportunistic pathogens. The possibility remains that antitumor drugs possess synergistic antimicrobial activity in combination with each other or with antibacterial therapeutic agents (7, 8) . Greater antibacterial effect due to regional concentration of drugs, such as in the gastrointestinal tract, also cannot be excluded by our data. Unfortunately, little is known about gastrointestinal concentrations of these drugs after intravenous administration.
The suggestion that the presence of antitumor agents in blood samples for culturing may delay detection of bactere-ANTIMICROB. AGENTS CHEMOTHER. (3) 1-100 5 >100 >100 2.5-5 >100 Enterobacter aerogenes (3) 5-50 5 >100 >100 5 >100 Enterobacter cloacae (3) 5-50 5-10 >100 >100 10 >100 Klebsiella pneumoniae (3) 5-50 5 >100 >100 5->100 >100 Salmonella enteritidis (2) 5 5 >100 >100 5 >100 Serratia marcescens (3) 0.5-5 1-5 >100 >100 >100 >100 Shigella sp. (2) 5-50 5 >100 >100 5 >100 Pseudomona's aeruginosa (4) 10-50 5 >500 >100 >100 >100 Branhamella catarrhalis (2) 50.1-0. Clostridium butyricum (1) 10 0.1 100 >100 >100 50 Clostridium cadaveris (1) >1,000 0.1 32 >100 >100 10 Clostridium difficile (4) 10-50 0.5 16-32 >100 >100 100->100 Clostridium perfringens (2) 100-500 0.1-0.5 16-100 >100 >100 10->100 (2) 50-1,000 0.5 500-1,000 >100 >100 >100 Bacteroides thetaiotaomicron (2) 1,000 0.1-0.5 500 50->100 >100 50->100 Bacteroides vulgatus (1) 500 0.5 500 >100 >100 >100
Fusobacterium mortiferum (1) >1,000 
